Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs

Journal of Law and Economics

Volumn 42, Issue 1, 1999, Pages 89-116

  Rizzo, John A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033480693     PISSN: 00222186     EISSN: None     Source Type: Journal    
DOI: 10.1086/467419     Document Type: Article

References (34)

1. Anonymous. "The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)." Archives of Internal Medicine 153, No. 2 (1993): 154-83.
2. Avorn, Jerry; Chen, Milton; and Hartley, Robert. "Scientific vs. Commercial Sources of Influence on the Prescribing Behaviors of Physicians." American Journal of Medicine 73, No. 1 (1982): 4-8.
3. Berndt, Ernst R. "Causality and Simultaneity between Advertising and Sales." In The Practice of Econometrics: Classic and Contemporary, edited by Ernst R. Berndt, pp. 361-448. Reading, Mass.: Addison-Wesley, 1991.
4. Bond, Ronald S., and Lean, David F. "Sales, Promotion, and Product Differentiation in Two Prescription Drug Markets." Staff Report to the Federal Trade Commission. Washington, D.C.: Federal Trade Commission, 1977.
5. Bowman, Marjorie A. "The Impact of Drug Company Funding on the Content of Continuing Medical Education." Mobius 6 (1986): 66-69.
6. Bowman, Marjorie A., and Pearle, David L. "Changes in Drug Prescribing Patterns Related to Commercial Company Funding of Continuing Medical Education." Journal of Continuing Education in the Health Professions 8 (1988): 13-20.
7. Brodsky, J. Frederick. "Letter to the Editor." New England Journal of Medicine 327, No. 23 (1992): 1687.
8. Caves, Richard E.; Whinston, Michael D.; and Hurwitz, Mark A. "Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry." Brookings Papers on Economic Activity: Microeconomics (1991), pp. 1-48.
9. Chren, Mary-Margaret, and Landefeld, C. Seth. "Physicians' Behavior and Their Interactions with Drug Companies." Journal of the American Medical Association 271, No. 9 (1994): 684-89.
10. Comanor, William S. "The Political Economy of the Pharmaceutical Industry." Journal of Economic Literature 24 (1986): 1178-1217.
11. Dorfman, Robert, and Steiner, Peter O. "Optimal Advertising and Optimal Quality." American Economic Review 44 (1954): 826-36.
12. Dustan, Harriet P.; Caplan, Louis R.; Curry, Charles L.; De Leon, Antonio C., Jr.; Douglas, Frank L. et al. "Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent." Circulation 85, No. 2 (1992): 849-60.
13. Economic Report of the President, 1994. Washington, D.C.: U.S. Government Printing Office, 1994.
14. Ellison, Sara F.; Cockburn, Iain; Griliches, Zvi; and Hausman, Jerry A. "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins." Mimeographed. Cambridge, Mass.: MIT, 1995.
15. Frank, Richard G., and Salkever, David S. "Pricing, Patent Loss and the Market for Pharmaceuticals." Southern Economic Journal 59, No. 2 (1992): 165-79.
16. Grabowski, Henry G., and Vernon, John M. "Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act." Journal of Law and Economics 35 (1992): 331-50.
17. Griliches, Zvi, and Cockburn, Iain. "Generics and New Goods in Pharmaceutical Price Indexes." American Economic Review 84, No. 5 (1994): 1213-32.
18. Hahn, Beth, and Lefkowitz, Doris. Annual Expenses and Sources of Payment for Health Care Services. AHCPR Publication No. 93-0007. National Medical Expenditure Survey Research Findings 14, Agency for Health Care Policy and Research. Rockville, Md.: Public Health Service, 1992.
19. Hurwitz, Mark A., and Caves, Richard E. "Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals." Journal of Law and Economics 31, No. 2 (1988): 299-320.
20. Kaplan, Norman M. "Treatment of Hypertension: Drug Therapy." In Clinical Hypertension, edited by Norman M. Kaplan, pp. 182-267. Baltimore: Williams & Wilkins, 1990.
21. Leffler, Keith B. "Persuasion or Information? The Economics of Prescription Drug Advertising." Journal of Law and Economics 24, No. 1 (1981): 45-74.
22. Lurie, Nicole; Rich, Eugene C.; Simpson, Deborah E.; Meyer, Jeff; Schiedermayer, David L. et al. "Pharmaceutical Sales Representatives in Academic Medical Centers: Interaction with Faculty and House Staff." Journal of General Internal Medicine 5, No. 3 (1990): 240-43.
23. McKinney, W. Paul; Schiedermayer, David L.; Lurie, Nicole; Simpson, Deborah E.; Goodman, Jesse L. et al. "Attitudes of Internal Medicine Faculty and Residents toward Professional Interaction with Pharmaceutical Sales Representatives." Journal of the American Medical Association 264, No. 13 (1990): 1693-97.
24. Nerlove, Marc, and Arrow, Kenneth J. "Optimal Advertising Policy under Dynamic Conditions." Economica 29 (1962): 129-42.
25. Orlowski, James P., and Wateska, Leon. "The Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns: There's No Such Thing as a Free Lunch." Chest 102, No. 1 (1992): 270-73.
26. Physicians Desk Reference. Montvale, N.J.: Medical Economics, Inc., 1993.
27. Rizzo, John A., and Zeckhauser, Richard J. "Advertising and Entry: The Case of Physician Services." Journal of Political Economy 98, No. 3 (1990): 476-500.
28. Rizzo, John A., and Zeckhauser, Richard J. "Advertising and the Price, Quantity, and Quality of Primary Care Physician Services." Journal of Human Resources 21, No. 3 (1992): 381-421.
29. Scherer, F. Michael. "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry." Journal of Economic Perspectives 7, No. 3 (1993): 97-115.
30. Telser, Lester G., et al. "The Theory of Supply with Applications to the Ethical Pharmaceutical Industry." Journal of Law and Economics 18, No. 2 (1975): 449-78.
31. Temin, Peter. Taking Your Medicine: Drug Regulation in the United States. Cambridge, Mass.: Harvard University Press, 1980.
32. U.S. Senate. Subcommittee on Antitrust and Monopoly. Report of the Study of Administered Prices in the Drug Industry. 87th Cong., 1st Sess., Washington, D.C., 1961.
33. Vernon, John M. "Concentration, Promotion, and Market Share Stability in the Pharmaceutical Industry." Journal of Industrial Economics 19, No. 3 (1971): 246-66.
34. Waud, Douglas R. (1992). "Pharmaceutical Promotions - A Free Lunch?" New England Journal of Medicine 327, No. 5 (1992): 351-53.